Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
P & T : a Peer-Reviewed Journal for Formulary Management|June 6, 2017
Cancer Immunotherapy, Part 1: Current Strategies and AgentsC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|April 11, 2015
The antibiotic resistance crisis: part 1: causes and threatsC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
Biosimilars: part 2: potential concerns and challenges for p&t committeesC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|November 15, 2014
Epilepsy management: newer agents, unmet needs, and future treatment strategiesC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|December 14, 2017
Progress in Nanomedicine: Approved and Investigational NanodrugsC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|July 14, 2016
Immunization in the United States: Recommendations, Barriers, and Measures to Improve Compliance: Part 1: Childhood VaccinationsC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|December 4, 2012
The nanomedicine revolution: part 3: regulatory and safety challengesC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|July 5, 2017
Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical ConsiderationsC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|November 26, 2013
Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variantsC Lee VentolaP & T : a Peer-Reviewed Journal for Formulary Management|August 16, 2013
Biosimilars: part 1: proposed regulatory criteria for FDA approvalC Lee VentolaPageof 3